<DOC>
	<DOC>NCT02442284</DOC>
	<brief_summary>This is a study to evaluate the safety and efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with or without Ribavirin in US veterans with genotype 1 chronic hepatitis C virus infection.</brief_summary>
	<brief_title>A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis C, Chronic</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<criteria>1. US military veteran currently receiving healthcare through the Veterans Health Administration 2. Screening laboratory result indicating HCV, genotype 1infection 3. Positive for hepatitis C antibodies or HCV RNA at least 6 months before Screening, and HCV RNA &gt; 1,000 IU/mL at the time of Screening or HCV RNA &gt; 1,000 IU/mL at the time of Screening with a liver biopsy consistent with chronic HCVinfection (or a liver biopsy performed prior to enrollment with evidence of chronic hepatitis C disease) 1. Women who are pregnant or breastfeeding 2. Positive test result for hepatitis B surface antigen (HbsAg) or antiHIV antibodies (HIV Ab) 3. Prior or current use of any investigational or commercially available antiHCV agents other than IFN, pegIFN, RBV or sofosbuvir 4. Any current or past clinical evidence of ChildPugh B or C classification 5. Confirmed presence of hepatocellular carcinoma indicated on imaging techniques within 3 months prior to Screening or on an ultrasound performed at Screening for participants with cirrhosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chronic Hepatitis C</keyword>
	<keyword>Interferon-Free</keyword>
	<keyword>Hepatitis C Genotype 1</keyword>
	<keyword>Hepatitis C Virus</keyword>
	<keyword>Hepatitis C</keyword>
	<keyword>Cirrhosis</keyword>
</DOC>